Market regulation · 10/04/1995Updated: 10/18/2026 · 1 min read

FDA Issues Rule for Child-Resistant Packaging of Lidocaine and Dibucaine Products

The US Food and Drug Administration (FDA) has issued a rule requiring child-resistant packaging for certain prescription and over-the-counter products containing lidocaine or dibucaine, in an effort to protect children under 5 years of age from serious harm